Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes [see comments]

Blood (1991) 78 (7): 1658–1663.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals